Emily Kaiser Maharjan, Assistant Managing Editor

Catch up on what happened in optometry during the week of November 27-December 1.

Catch up on what happened in optometry during the week of November 20-November 24.

Using the NEI protocol for addressing corneal staining, researchers used 5 microliters of 2%, non preserved fluorescein and then evaluated corneal staining.

Hear about the new innovations on the market—and coming soon—from Alcon.

ONE by ONE and Biotrue Eye Care Recycling programs from Bausch + Lomb have collected over 464,100 pounds of used contact lens materials that would have otherwise been sent to a landfill.

A rapid-fire, top-level review of what happened in optometry in 2023.

Hear how this daily disposable silicone hydrogel option fits patients' busy and active lifestyles.

Hear how the Clek study continues to play a role in today's keratoconus care.

Optometry Times sat down with Carla Calizaire, Global Leader of Diversity Inclusion for Johnson and Johnson Med Tech to go in depth about the Vision Made Possible and Sight for Kids campaign.

The 2023 American Academy of Optometry annual meeting showcased excellent science and insightful education.

Patients who have signs or symptoms of an eye infection after using these products should talk to their health care provider or seek medical care immediately.

The FDA recalled 26 eye drops due to risk of infection and possible vision loss.

Optometrists must consider the experience of the person in the chair.

At the 2023 AAOpt annual meeting, data was presented on the frequency of success of patients struggling with contact lens drop out getting back into daily disposable lenses.

Traditionally hosted in New York City, Vision Expo East will be held in Orlando, Florida, beginning in 2025.

Tracy Doll, OD, FAAO, shares an overview of her anterior segment symposium presented during the 2023 AAOpt annual meeting.

Qlosi (Orasis Pharmaceuticals) approved to treat presbyopia.

Learn what's in the pipeline for eSight, as well as hear how their current technology helps patients.

As new treatment options continue to enter the glaucoma space, clinicians can provide the best care to each individual patient.

A rapid fire session details what's in the pipeline for ocular surface dryness therapies.

CSF-1 (0.4% pilocarpine HCl), a presbyopia-correcting drop candidate from Orasis, demonstrated consistent pupil restriction, which also suggests neuroadaptation in patients with presbyopia to the drop over time.

Jeffrey J. Walline, OD, PhD, discusses the 2023 AAOpt keynote speech, "Mental Health and Optometry."

Tracy Doll, OD, FAAO, chats about the AAOpt session "Sunny With a Chance of Tears: What's in the Forecast for Ocular Surface Dryness Therapies?"

Karen G. Carrasquillo, OD, PhD, FAAO, FSLS, FBCLA, shares highlights from her 2023 AAOpt presentations on scleral lenses, as well as cultural competency.

Therapies and technologies to treat allergic conjunctivitis are rapidly changing.

Shalu Pal, BSc, OD, FAAO, chats about fitting soft, gas permeable, scleral, and hybrid lenses based on her AAOpt ACE course she presented alongside her ACE course, "Multifocal Fitting Tips for Soft, GP, Scleral and Hybrid Lenses," which she presented alongside Melissa Barnett, OD, FAAO, FSLS, FBCLA.

At AAOpt, Nate Lighthizer, OD, presents a variety of lectures and workshops on lasers and their use in optometry.

Optometry Times sat down with Mohammad Rafieetary, OD, FAAO, FORS, Dipl ABO, ABCMO, to discuss his upcoming presentations at AAOpt.

Ariel Cerenzie, OD, FAAO, FSLS, shares highlights from the recently released Contact Lens Institute report on contact lens culture.